Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) CEO Margaret Tooth sold 1,000 shares of Trupanion stock in a transaction on Friday, September 11th. The stock was sold at an average price of $25.00, for a total transaction of $25,000.00. Following the transaction, the chief executive officer owned 185,952 shares in the company, valued at $4,648,800. This represents a 0.53% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Margaret Tooth also recently made the following trade(s):
- On Tuesday, August 25th, Margaret Tooth sold 491 shares of Trupanion stock. The shares were sold at an average price of $31.84, for a total transaction of $15,633.44.
- On Tuesday, August 11th, Margaret Tooth sold 978 shares of Trupanion stock. The stock was sold at an average price of $29.05, for a total value of $28,410.90.
Trupanion Stock Performance
Trupanion stock traded up $0.17 during trading on Tuesday, reaching $26.32. The company had a trading volume of 414,065 shares, compared to its average volume of 439,054. The firm has a market capitalization of $1.15 billion, a price-to-earnings ratio of 49.66, a price-to-earnings-growth ratio of 1.68 and a beta of 1.45. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.24. The firm’s 50-day simple moving average is $27.39 and its 200 day simple moving average is $25.77. Trupanion, Inc. has a 52 week low of $21.16 and a 52 week high of $46.98.
Analyst Upgrades and Downgrades
Several equities research analysts recently issued reports on the stock. Weiss Ratings lowered shares of Trupanion from a “hold (c)” rating to a “hold (c-)” rating in a report on Thursday. Piper Sandler lowered shares of Trupanion from an “overweight” rating to a “neutral” rating and dropped their price target for the stock from $45.00 to $32.00 in a research report on Wednesday, August 26th. Stifel Nicolaus increased their price objective on shares of Trupanion from $28.00 to $29.00 and gave the stock a “hold” rating in a research note on Thursday, August 20th. Atlantic Securities set a $42.00 price target on Trupanion in a report on Wednesday, July 15th. Finally, Zacks Research downgraded Trupanion from a “strong-buy” rating to a “hold” rating in a research report on Monday, August 24th. One analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $39.20.
View Our Latest Report on TRUP
Hedge Funds Weigh In On Trupanion
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Kelleher Financial Advisors bought a new position in shares of Trupanion during the 2nd quarter valued at about $42,000. Parallel Advisors LLC increased its holdings in shares of Trupanion by 1,831.9% in the first quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock worth $47,000 after purchasing an additional 1,722 shares during the last quarter. Quantbot Technologies LP purchased a new stake in shares of Trupanion in the second quarter worth about $89,000. Fifth Third Bancorp lifted its position in shares of Trupanion by 2,911.1% in the first quarter. Fifth Third Bancorp now owns 7,588 shares of the financial services provider’s stock worth $194,000 after buying an additional 7,336 shares in the last quarter. Finally, Arizona State Retirement System boosted its stake in Trupanion by 7.7% during the second quarter. Arizona State Retirement System now owns 9,587 shares of the financial services provider’s stock valued at $237,000 after buying an additional 688 shares during the last quarter.
About Trupanion
Trupanion, Inc is a pet insurance company that provides medical coverage for cats and dogs. Its subscription-based policies are designed to help pet owners manage the cost of eligible veterinary care, including coverage for unexpected illnesses and injuries. Depending on the policy and jurisdiction, coverage may include diagnostic tests, surgeries, hospital stays and prescription medications, subject to applicable terms, exclusions and deductibles.
The company also develops technology intended to simplify the relationship between pet owners, veterinarians and insurers.
See Also
- Five stocks we like better than Trupanion
- Running on Empty: 3 Energy Plays for Europe’s Deep Freeze
- 3 Healthcare Stocks for 3 Stages of Life
- Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid
- MarketBeat’s Most Downgraded Stocks in Q3: 2 Look Cheap, 1 Looks Risky
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
